UY33511A - Procedimiento de obtención de la forma cristalina ii del febuxostat - Google Patents
Procedimiento de obtención de la forma cristalina ii del febuxostatInfo
- Publication number
- UY33511A UY33511A UY0001033511A UY33511A UY33511A UY 33511 A UY33511 A UY 33511A UY 0001033511 A UY0001033511 A UY 0001033511A UY 33511 A UY33511 A UY 33511A UY 33511 A UY33511 A UY 33511A
- Authority
- UY
- Uruguay
- Prior art keywords
- febuxostat
- obtaining
- procedure
- crystal form
- crystallization
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La invención se refiere a un nuevo procedimiento de obtención de la forma cristalina II del Febuxostat por cristalización en un disolvente elegido entre acetato de etilo, acetato de metilo o formiato de etilo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201031061 | 2010-07-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY33511A true UY33511A (es) | 2012-01-31 |
Family
ID=44533538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001033511A UY33511A (es) | 2010-07-13 | 2011-07-13 | Procedimiento de obtención de la forma cristalina ii del febuxostat |
Country Status (7)
Country | Link |
---|---|
US (1) | US20130184466A1 (es) |
EP (1) | EP2593442A1 (es) |
JP (1) | JP2013531021A (es) |
AR (2) | AR081267A1 (es) |
TW (1) | TW201217346A (es) |
UY (1) | UY33511A (es) |
WO (1) | WO2012007487A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2619191A4 (en) | 2010-09-24 | 2014-03-26 | Hetero Research Foundation | NEW POLYMORPHS OF FEBUXOSTAT |
WO2012168948A2 (en) | 2011-06-06 | 2012-12-13 | Hetero Research Foundation | Process for febuxostat |
JP2014533297A (ja) * | 2011-11-15 | 2014-12-11 | マイラン ラボラトリーズ リミテッドMylan Laboratories Limited | フェブキソスタットの多形の調製方法 |
EP2692342A1 (en) | 2012-07-30 | 2014-02-05 | Interquim, S.A. | Process for the preparation of pharmaceutical compositions comprising febuxostat in the form of tablets |
EP3002006A1 (en) | 2014-10-01 | 2016-04-06 | Bluepharma - Industria Farmacêutica, S.A. | Pharmaceutical composition capable for the incorporation Febuxostat in the crystalline modifications F10, II, G and A |
CN110526879B (zh) * | 2019-08-28 | 2022-06-21 | 迪嘉药业集团有限公司 | 一种小粒度非布司他的结晶制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU218942B (hu) * | 1990-11-30 | 2001-01-29 | Teijin Ltd. | 2-Fenil-tiazol-származékok, az ezeket tartalmazó gyógyászati készítmények, valamint eljárás a vegyületek előállítására |
CN101139325B (zh) | 2006-09-07 | 2010-05-12 | 上海医药工业研究院 | 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法 |
CN100546985C (zh) * | 2007-06-29 | 2009-10-07 | 上海华拓医药科技发展股份有限公司 | 非布他特微晶及其组合物 |
CN101412700B (zh) | 2007-10-19 | 2011-06-08 | 上海医药工业研究院 | 非布司他的晶型及其制备方法 |
-
2011
- 2011-05-31 AR ARP110101868A patent/AR081267A1/es not_active Application Discontinuation
- 2011-06-24 AR ARP110102208A patent/AR081659A1/es unknown
- 2011-07-11 TW TW100124419A patent/TW201217346A/zh unknown
- 2011-07-13 US US13/809,839 patent/US20130184466A1/en not_active Abandoned
- 2011-07-13 JP JP2013519084A patent/JP2013531021A/ja not_active Withdrawn
- 2011-07-13 WO PCT/EP2011/061906 patent/WO2012007487A1/en active Application Filing
- 2011-07-13 EP EP11736321.8A patent/EP2593442A1/en not_active Withdrawn
- 2011-07-13 UY UY0001033511A patent/UY33511A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2593442A1 (en) | 2013-05-22 |
TW201217346A (en) | 2012-05-01 |
AR081659A1 (es) | 2012-10-10 |
JP2013531021A (ja) | 2013-08-01 |
WO2012007487A1 (en) | 2012-01-19 |
US20130184466A1 (en) | 2013-07-18 |
AR081267A1 (es) | 2012-07-18 |
WO2012007487A9 (en) | 2012-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011119004A3 (en) | Method of producing d-psicose crystals | |
PL2531286T3 (pl) | Sposób syntezy metanolu | |
EP2709970A4 (en) | INTEGRATED PROCESS FOR THE PREPARATION OF 1-CHLORO-3,3,3-TRIFLUORPROPENES | |
SG11201400291YA (en) | Process for producing n-(hetero)arylazoles | |
DK3210978T3 (da) | Fremgangsmåde til fremstilling af acesulfamkalium | |
UY33511A (es) | Procedimiento de obtención de la forma cristalina ii del febuxostat | |
BR112013019520A2 (pt) | método para produção de 2,3-butanodiol por fermentação | |
ZA201404218B (en) | Process for the production of furfural | |
WO2013121436A3 (en) | A process for preparation of rivaroxaban and intermediates thereof | |
EP2455515A4 (en) | PRODUCTION PROCESS OF MONOCRISTAL SIC | |
DK2697356T3 (da) | Fremgangsmåde til fremstilling af ølurt | |
WO2012015999A3 (en) | Process for the preparation of imatinib mesylate | |
EP2797906A4 (en) | PROCESS FOR THE PREPARATION OF FURFURAL | |
EP2690204A4 (en) | METHOD FOR PRODUCING A NITRIDE CRYSTAL | |
IN2014DN06964A (es) | ||
MY163214A (en) | Synthesis of 2-carboxamide cycloamino urea dervatives | |
EP2708530A4 (en) | STEREO-SPECIFIC SYNTHESIS PROCESS FOR TRETINOINE COMPOUNDS | |
WO2014087208A3 (en) | A process of preparing alcaftadine | |
UY33510A (es) | Procedimiento de obtencion de la forma cristalina a del febuxostat | |
WO2012174229A3 (en) | Methods for the synthesis and purification of deoxycholic acid | |
IN2014DN09451A (es) | ||
WO2013072938A3 (en) | Process for the preparation of roflumilast | |
PL2604592T3 (pl) | Sposób oczyszczania aniracetamu przez krystalizacje z roztworów wodnych | |
DK2477971T3 (da) | Fremgangsmåde til syntese af 5-amino-1-phenyl-3-cyan-4-triflourmethylsulfinylpyrazol | |
WO2014170909A3 (en) | Process for pomalidomide |